- 3 次围观
产品图片
货号/SKU
NR-52200
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、2
产品描述信息
NR-52200??Acinetobacter baumannii, MRSN 15574(Bacteria)|Acinetobacter baumannii|MRSN 15574|-60°C or colder|MRSN/WRAIRAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Acinetobacter baumannii, Strain MRSN 15574, NR-52200. This strain is part of the Acinetobacter baumannii Diversity Panel provided by the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR).”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
This item is currently in our production queue. Please allow ample time for distribution lots to be made available.
Acinetobacter baumannii (A. baumannii), strain MRSN 15574 was isolated in 2012 from a human respiratory sample in Europe as part of a global surveillance program.
A. baumannii, strain MRSN 15574 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52200 was deposited as multi-locus sequence type (MLST) ST 85, sensitive to amikacin and colistin, and resistant to ampicillin/sulbactam, ceftazidime, ciprofloxacin, ceftriaxone, cefepime, gentamicin, imipenem, trimethoprim/sulfamethoxazole, levofloxacin, meropenem, tobramycin and tetracycline. Strain MRSN 15574 is reported to have three aminoglycoside transferase genes [ant(2”)-Ia, ant(3”)-IIa and aph(3')-VI; conferring resistance to various aminoglycosides], three beta-lactamase genes (blaADC-25, blaNDM-1 and blaOXA-94; conferring resistance to beta-lactams), a macrolide phosphotransferase gene [mph(E); conferring resistance to macrolides], a ABC-F type ribosomal protection protein gene [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics], a sulfonamide resistance gene (sul2; conferring resistance to sulfonamides) and a tetracycline resistance gene [tet(39); conferring resistance to tetracycline]. The complete genome of A. baumannii, strain MRSN 15574 is available (GenBank: VHGP00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
This item is currently in our production queue. Please allow ample time for distribution lots to be made available.
Acinetobacter baumannii (A. baumannii), strain MRSN 15574 was isolated in 2012 from a human respiratory sample in Europe as part of a global surveillance program.
A. baumannii, strain MRSN 15574 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52200 was deposited as multi-locus sequence type (MLST) ST 85, sensitive to amikacin and colistin, and resistant to ampicillin/sulbactam, ceftazidime, ciprofloxacin, ceftriaxone, cefepime, gentamicin, imipenem, trimethoprim/sulfamethoxazole, levofloxacin, meropenem, tobramycin and tetracycline. Strain MRSN 15574 is reported to have three aminoglycoside transferase genes [ant(2”)-Ia, ant(3”)-IIa and aph(3')-VI; conferring resistance to various aminoglycosides], three beta-lactamase genes (blaADC-25, blaNDM-1 and blaOXA-94; conferring resistance to beta-lactams), a macrolide phosphotransferase gene [mph(E); conferring resistance to macrolides], a ABC-F type ribosomal protection protein gene [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics], a sulfonamide resistance gene (sul2; conferring resistance to sulfonamides) and a tetracycline resistance gene [tet(39); conferring resistance to tetracycline]. The complete genome of A. baumannii, strain MRSN 15574 is available (GenBank: VHGP00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.通过此限制的订单将在发货前发送至NIAID进行批准.
此项目目前处于我们的生产队列中.请允许充足的时间进行分销批次.
AcineTobacterBaumannii(A.Baumannii),菌株MRSN 15574于2012年从欧洲的人类呼吸样品中分离出作为全球监督计划的一部分.
a. Baumannii ,菌株MRSN 15574作为MRSN 的一部分沉积,Baumannii 从BEI资源获得的多样性面板作为NR-52248. NR-52200沉积为多基因座序列类型(MLST)ST 85,对Amikacin和Colistin敏感,并抗氨苄青霉素/苏术酰胺,头孢唑胺,CiProfloxacin,Ceftriaxone,Cefepime,庆大霉素,Imipenem,Trimethokim / Sulfamethoxazole,Levofloxacin,Meropenem,杂草霉素和四环素.据报道,菌株MRSN 15574具有三种氨基糖苷类转移酶基因[蚂蚁,(2“) - Ia,蚂蚁(3”) - IIA和 APH (3') - vi;赋予各种氨基糖苷的耐药性,三种β-内酰胺酶基因( BLA ADC-25 , BLA Ndm-1 和 Bla oxa-94 ;赋予β-内酰胺的抗性),一种大环内酯磷酸转移酶基因[ mph (e);赋予大胶质剂的耐药性,ABC-F型核糖体保护蛋白基因[ MSR (E);赋予红霉素和链图B抗生素的耐药性,磺酰胺含量抗性基因(Sul 2;赋予磺胺酰胺抗性)和四环素抗性基因[ TET (39);赋予四环素的抵抗力. a的完整基因组. Baumannii ,菌株MRSN 15574可用(GenBank:).
每个小瓶含有约0.5ml的胰蛋白酶肉汤中的细菌培养,补充有10%甘油.
patric (Pathosystems资源集成中心)提供了其他信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2024-08-16
2022-04-01
2024-05-19
2022-04-01
2024-05-19
2022-04-01
2022-04-01
2022-04-01
2021-12-02
2022-04-01
2022-03-31
2019-05-08
2021-12-21
2024-02-26
2022-04-01
2024-05-19
2022-04-01